Novel Mechanisms that Restore Cardiac Parasympathetic Activity Limits Arrhythmias and Cardiac Dysfunction After Myocardial Infarction

恢复心脏副交感神经活动的新机制可限制心肌梗死后的心律失常和心脏功能障碍

基本信息

  • 批准号:
    10366054
  • 负责人:
  • 金额:
    $ 57.92万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-04-10 至 2024-03-31
  • 项目状态:
    已结题

项目摘要

Sudden Cardiac Death (SCD) is responsible for between 15 and 20% of all deaths, and ~50% of all cardiovascular deaths in the United States. The most common cascade of events leading to SCD is acute coronary syndrome (ACS) progressing to acute myocardial ischemia and/or inflammation that triggers electrical instability and lethal arrhythmias. Preventing SCD is particularly difficult as approximately one-half of men and two-thirds of women who succumb to SCD had no known history of prior heart disease. Autonomic imbalance is a major risk factor for SCD. Augmented sympathetic activity induces changes in ECG repolarization and reduction of fibrillation threshold facilitating the initiation of ventricular fibrillation (VF). In contrast, the generation of fatal ventricular arrhythmias and risk of SCD is markedly reduced by increasing parasympathetic activity. However a rapid, safe and feasible approach to increase parasympathetic activity to the heart in patients at risk for fatal arrhythmias is severely lacking and is a major medical need. Our preliminary results provide critical new information for the field that identifies a novel target that could restore parasympathetic cardiac tone and reduce the incidence of arrhythmias and cardiac dysfunction following a MI. Our prior work in subjects with sleep apnea has shown intranasal (IN) application of oxytocin increases parasympathetic cardiac activity. In an animal model of ACS with ligation of the left anterior descending coronary artery (LAD) animals develop ischemia, arrhythmias and mortality similar to clinical studies. We show that LAD-ligated animals have reduced endogenous excitatory oxytocin-mediated neurotransmission to parasympathetic cardiac vagal neurons (CVNs) in the brainstem. We further show that selective and chronic activation of hypothalamic paraventricular nucleus (PVN) oxytocin neurons restores oxytocin release, increases parasympathetic activity to the heart and substantially reduces the incidence and initiation of arrhythmias, inflammation, fibrosis and other adverse cardiac outcomes. Based upon our novel results, our overall hypothesis is that chronic selective activation of PVN oxytocin neurons, as well as nasal oxytocin administration, markedly reduces arrhythmias and cardiac dysfunction in an animal model of ACS. In Aim 1 we will test the hypothesis that the critical excitatory pathway from PVN oxytocin neurons to CVNs that helps maintain protective parasympathetic activity to the heart is blunted in animals following LAD ligation, and that this key neurotransmission can be restored with nasal oxytocin treatment and chronic and selective activation of PVN oxytocin neurons. In Aim 2 we will test whether treatment by nasal oxytocin and chronic and selective activation of PVN oxytocin neurons increases parasympathetic activity to the heart in-vivo, reduce the incidence of arrhythmias, improves autonomic balance and effort capacity in exercise stress tests and cardiac function. In Aim 3 we will quantify the electrical and mechanical function of ex-vivo perfused hearts to identify the mechanisms responsible for the cardiac benefits of nasal oxytocin and selective activation of PVN oxytocin neurons in LAD-ligated animals.
心脏性猝死(SCD)占所有死亡的15%至20%,约占所有死亡人数的50% 美国的心血管死亡人数。导致SCD的最常见的事件级联是急性的 冠状动脉综合征(ACS)进展为急性心肌缺血和/或炎症,引发电击 不稳定和致命性心律失常。预防SCD尤其困难,因为大约一半的男性和 三分之二死于SCD的女性之前没有已知的心脏病病史。自主神经失衡 是SCD的主要危险因素。交感神经活动增强导致心电复极和 降低颤动阈值有利于室颤的发生。相比之下, 增加副交感神经可显著降低致命性室性心律失常的发生和SCD的风险 活动。然而,一种快速、安全和可行的方法来增加心脏的副交感神经活动 严重缺乏有致命心律失常风险的患者,这是一项主要的医疗需求。我们的初步结果 为识别可以恢复副交感神经的新靶点提供关键的新信息 并减少心肌梗塞后心律失常和心功能不全的发生率。我们之前的工作是 睡眠呼吸暂停患者经鼻(IN)应用催产素可增加副交感神经功能 活动。结扎冠状动脉左前降支建立急性冠脉综合征动物模型 出现类似于临床研究的缺血、心律失常和死亡率。我们证明了LAD结扎的动物 内源性兴奋性催产素介导的心脏迷走神经副交感神经传递减少 脑干的神经元(CVN)。我们进一步表明,选择性和慢性激活下丘脑 室旁核(PVN)催产素神经元恢复催产素释放,增加副交感神经活动 并大大减少心律失常、炎症、纤维化和心脏疾病的发生和发生 其他心脏不良后果。基于我们的新结果,我们的总体假设是慢性选择性 激活下丘脑室旁核催产素神经元,以及鼻腔注射催产素,可显著减少心律失常 以及在急性冠脉综合征动物模型中的心脏功能障碍。在目标1中,我们将检验这样的假设,即关键的 PVN催产素神经元至CVN的兴奋通路有助于维持保护性副交感神经活动 在左前降支结扎后,心脏的这一关键神经传递可以恢复。 鼻腔催产素治疗和慢性选择性激活下丘脑室旁核催产素神经元。在《目标2》中我们将 鼻腔催产素治疗与PVN催产素神经元慢性选择性激活的关系 增加体内对心脏的副交感神经活动,减少心律失常的发生,改善 运动负荷试验中的自主神经平衡和努力能力以及心脏功能。在目标3中,我们将量化 体外灌流心脏的电和机械功能以确定导致心脏死亡的机制 鼻腔催产素和选择性激活下丘脑室旁核催产素神经元对LAD结扎动物心脏的益处。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Matthew W. Kay其他文献

Feasibility of Long-Distance Transfer for High Resolution Optical Mapping of Cardiac Tissue Constructs
  • DOI:
    10.1016/j.bpj.2011.11.3677
  • 发表时间:
    2012-01-31
  • 期刊:
  • 影响因子:
  • 作者:
    Nina Tandon;Luther M. Swift;Matthew W. Kay;Gordana Vunjak-Novakovic;Narine Sarvazyan
  • 通讯作者:
    Narine Sarvazyan
PO-05-140 NADH CATHETER MAPPING IDENTIFIES GAP FORMATION BETWEEN PULSED FIELD ABLATION LESIONS
PO-05-140 NADH 导管测绘识别脉冲场消融病变之间的间隙形成
  • DOI:
    10.1016/j.hrthm.2025.03.1538
  • 发表时间:
    2025-04-01
  • 期刊:
  • 影响因子:
    5.700
  • 作者:
    Rebekah Russo;Terry Ransbury;Catherine Ruffino;Bridget Alber;Omar Amirana;Narine Sarvazyan;Matthew W. Kay
  • 通讯作者:
    Matthew W. Kay
The Inter-Dependency of Local Myocardial Metabolism and Epicardial Electrical Activity during Acute Ischemia and Reperfusion
  • DOI:
    10.1016/j.bpj.2009.12.2879
  • 发表时间:
    2010-01-01
  • 期刊:
  • 影响因子:
  • 作者:
    Huda Asfour;Luther M. Swift;Alta Berger;Ara Arutunyan;Narine Sarvazyan;Matthew W. Kay
  • 通讯作者:
    Matthew W. Kay
Exploring the Effects of Conduction Reserve and Ephaptic Coupling in Cardiac Cells
  • DOI:
    10.1016/j.bpj.2019.11.2733
  • 发表时间:
    2020-02-07
  • 期刊:
  • 影响因子:
  • 作者:
    Joyce Lin;Steven Poelzing;Sharon A. George;Amara Greer-Short;Matthew W. Kay
  • 通讯作者:
    Matthew W. Kay
MP-470543-008 PANORAMIC HYPERSPECTRAL OPTICAL MAPPING OF CARDIAC MEMBRANE POTENTIAL AND TISSUE TYPE IN INFARCTED HEARTS
MP-470543-008 梗死心脏中心肌膜电位和组织类型的全景高光谱光学映射
  • DOI:
    10.1016/j.hrthm.2024.03.371
  • 发表时间:
    2024-05-01
  • 期刊:
  • 影响因子:
    5.700
  • 作者:
    Grant Kowalik;Murray Loew;Emilia Entcheva;Matthew W. Kay
  • 通讯作者:
    Matthew W. Kay

Matthew W. Kay的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Matthew W. Kay', 18)}}的其他基金

Novel Mechanisms that Restore Cardiac Parasympathetic Activity Limits Arrhythmias and Cardiac Dysfunction After Myocardial Infarction
恢复心脏副交感神经活动的新机制可限制心肌梗死后的心律失常和心脏功能障碍
  • 批准号:
    10604331
  • 财政年份:
    2020
  • 资助金额:
    $ 57.92万
  • 项目类别:
Novel Mechanisms that Restore Cardiac Parasympathetic Activity Limits Arrhythmias and Cardiac Dysfunction After Myocardial Infarction
恢复心脏副交感神经活动的新机制可限制心肌梗死后的心律失常和心脏功能障碍
  • 批准号:
    9981104
  • 财政年份:
    2020
  • 资助金额:
    $ 57.92万
  • 项目类别:
Hypothalamic neuron activation to blunt myocardial remodeling during chronic sleep apnea
下丘脑神经元激活可减弱慢性睡眠呼吸暂停期间的心肌重塑
  • 批准号:
    10321896
  • 财政年份:
    2018
  • 资助金额:
    $ 57.92万
  • 项目类别:
Oxygen-rich perfusate that is compatible with optical assessments of myocardial physiology
与心肌生理学光学评估兼容的富氧灌注液
  • 批准号:
    9252529
  • 财政年份:
    2016
  • 资助金额:
    $ 57.92万
  • 项目类别:
Oxygen-rich perfusate that is compatible with optical assessments of myocardial physiology
与心肌生理学光学评估兼容的富氧灌注液
  • 批准号:
    9112060
  • 财政年份:
    2016
  • 资助金额:
    $ 57.92万
  • 项目类别:
Low flow reperfusion after acute myocardial ischemia: when too little is too much
急性心肌缺血后的低流量再灌注:太少就是太多
  • 批准号:
    8454499
  • 财政年份:
    2010
  • 资助金额:
    $ 57.92万
  • 项目类别:
Low flow reperfusion after acute myocardial ischemia: when too little is too much
急性心肌缺血后的低流量再灌注:太少就是太多
  • 批准号:
    7889518
  • 财政年份:
    2010
  • 资助金额:
    $ 57.92万
  • 项目类别:
Low flow reperfusion after acute myocardial ischemia: when too little is too much
急性心肌缺血后的低流量再灌注:太少就是太多
  • 批准号:
    8645695
  • 财政年份:
    2010
  • 资助金额:
    $ 57.92万
  • 项目类别:
Low flow reperfusion after acute myocardial ischemia: when too little is too much
急性心肌缺血后的低流量再灌注:太少就是太多
  • 批准号:
    8063598
  • 财政年份:
    2010
  • 资助金额:
    $ 57.92万
  • 项目类别:
Low flow reperfusion after acute myocardial ischemia: when too little is too much
急性心肌缺血后的低流量再灌注:太少就是太多
  • 批准号:
    8238372
  • 财政年份:
    2010
  • 资助金额:
    $ 57.92万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 57.92万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 57.92万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 57.92万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 57.92万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 57.92万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 57.92万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 57.92万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 57.92万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 57.92万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 57.92万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了